Biology of Blood and Marrow Transplantation
Volume 12, Issue 11 , Pages 1101-1113 , November 2006

Cutaneous Manifestations of Chronic Graft-versus-Host Disease

  • Sharon R. Hymes

      Affiliations

    • Department of Dermatology, The MD Anderson Cancer Center, Houston, Texas
    • Corresponding Author InformationCorrespondence and reprint requests: Sharon R. Hymes, MD, Department of Dermatology, The MD Anderson Cancer Center, Unit 434, FC5.3004, Houston, TX 77030.
    • ,
  • Maria L. Turner

      Affiliations

    • Dermatology Branch, National Cancer Institute, Bethesda, Maryland
    • ,
  • Richard E. Champlin

      Affiliations

    • Department of Blood and Marrow Transplantation, The MD Anderson Cancer Center, Houston, Texas
    • ,
  • Daniel R. Couriel

      Affiliations

    • Department of Blood and Marrow Transplantation, The MD Anderson Cancer Center, Houston, Texas

Received 11 August 2006 ,Accepted 29 August 2006.

References 

  1. Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II (Pathology Working Group Report). Biol Blood Marrow Transplant. 2006;12:31–47
  2. Beers B, Kalish RS, Kaye VN, Dahl MV. Unilateral linear lichenoid eruption after bone marrow transplantation: an unmasking of tolerance to an abnormal keratinocyte clone?. J Am Acad Dermatol. 1993;28:888–892
  3. Schauder CS, Hymes SR, Rapini RP, Zipf TF. Vesicular graft-versus-host disease. Int J Dermatol. 1992;31:509–510
  4. Aractingi S, Janin A, Devergie A, Bourges M, Socie G, Gluckman E. Histochemical and ultrastructural study of diffuse melanoderma after bone marrow transplantation. Br J Dermatol. 1996;134:325–331
  5. Kossard S, Ma DD. Acral keratotic graft versus host disease simulating warts. Australas J Dermatol. 1999;40:161–163
  6. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV (Response Criteria Working Group Report). Biol Blood Marrow Transplant. 2006;12:252–266
  7. Lacour JP, Sirvent N, Monpoux F, et al. Dermatotmal chronic cutaneous graft-versus-host disease at the site of prior herpes zoster. Br J Dermatol. 1999;141:587–589
  8. Cohen PR, Hymes SR. Linear and dermatomal cutaneous graft-versus-host disease. South Med J. 1994;87:758–761
  9. Penas PF, Jones-Caballero M, Aragues M, Fernandez-Herrera J, Fraga J, Garcia-Diez A. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol. 2002;138:924–934
  10. Aractingi S, Socie G, Devergie A, Dubertret L, Gluckman E. Localized scleroderma-like lesions on the legs in bone marrow transplant recipients: association with polyneuropathy in the same distribution. Br J Dermatol. 1993;129:201–203
  11. Garnis S, Billick RC, Srolovitz H. Eruptive vascular tumors associated with chronic graft-versus-host disease. J Am Acad Dermatol. 1984;10:918–921
  12. Soo JK, Mortimer PS. Eruptive angiomas associated with graft-versus-host disease. Br J Dermatol. 2006;154:376–378
  13. Hymes SR, Farmer ER, Burns WH, et al. Bullous sclerodermalike changes in chronic graft-vs-host disease. Arch Dermatol. 1985;121:1189–1192
  14. Janin A, Socie G, Devergie A, et al. Fasciitis in chronic graft-versus-host disease (A clinicopathologic study of 14 cases). Ann Intern Med. 1994;120:993–998
  15. Gottlober P, Leiter U, Friedrich W, et al. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography. J Eur Acad Dermatol Venereol. 2003;17:402–407
  16. Sanli H, Arat M, Oskay T, Gurman G. Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: a single-center study from Turkey. Int J Dermatol. 2004;43:176–180
  17. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267–276
  18. Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol. 1998;134:602–612
  19. Grundmann-Kollmann M, Martin H, Ludwig R, et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation. 2002;74:1631–1634
  20. Abdelsayed RA, Sumner T, Allen CM, Treadway A, Ness GM, Penza SL. Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:75–80
  21. Nagler RM, Nagler A. Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment. Isr Med Assoc J. 2004;6:167–172
  22. Spinelli S, Chiodi S, Costantini S, et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica. 2003;88:1163–1168
  23. Spiryda LB, Laufer MR, Soiffer RJ, Antin JA. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biol Blood Marrow Transplant. 2003;9:760–765
  24. Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V (Ancillary Therapy and Supportive Care Working Group Report). Biol Blood Marrow Transplant. 2006;12:375–396
  25. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I (Diagnosis and staging working group report). Biol Blood Marrow Transplant. 2005;11:945–956

PII: S1083-8791(06)00604-5

doi: 10.1016/j.bbmt.2006.08.043

Biology of Blood and Marrow Transplantation
Volume 12, Issue 11 , Pages 1101-1113 , November 2006

Article Tools

* Image Usage & Resolution